Carnegie Investment Counsel grew its position in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 11.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange ...

DexCom (NASDAQ:DXCM – Get Free Report) was upgraded by stock analysts at Robert W. Baird from a “neutral” rating to an ...

DexCom's stock is fairly valued despite positive Q4 2024 results, with muted enthusiasm from Wall Street today. Click here to ...

Latin America continuous glucose monitoring device market is estimated to be valued at US$ 219.3 mn in 2025 and is expected to exhibit a CAGR of 15.8% by 2032 ...

Stocks tend to perform well in January, but that's not a good reason to invest this month. Strong returns aren't made in a ...

In a report released today, Jeff Johnson from Robert W. Baird upgraded Dexcom (DXCM – Research Report) to a Buy, with a price target of ...

Kevin Sayer said at the J.P. Morgan Healthcare Conference that Dexcom also expects to release a 15-day glucose sensor in the ...

Semaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...

Buoyed by the recent launch of Stelo and further upcoming CGM launches, Dexcom is anticipating a 14% growth in 2025 over 2024 ...

The latest edition of STAT’s Health Tech newsletter brings you important dispatches from the J.P. Morgan Health Care ...

In a report released yesterday, William Plovanic from Canaccord Genuity maintained a Buy rating on Dexcom (DXCM – Research Report), with a ...

Shelomi Sanders, the youngest daughter of Hall of Famer Deion Sanders, began 2025 with a resolution to care for her health.